Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stock markets flat ahead of quiet day

Fri, 13th Mar 2015 09:06

UK stocks were more or less flat in early deals on Friday ahead of a quiet day for the markets in terms of economic data and corporate news.London's FTSE 100 was trading up just 0.01% at 6,761.79 early on.As it stands, the Footsie is still nearly 3% lower than where it stood last Friday as a strengthening pound and weak Chinese data weighed on commodity prices, while ongoing concerns about Greek continued to hit sentiment.Friday is set to be a quiet day in terms of economic data, with UK construction output, the US producer price index (PPI) and University of Michigan (UoM) consumer confidence survey the only major indicators being released."The PPI reading can be a good indicator of future inflation so is worth tracking, while the UoM reading could give some insight into consumer spending expectations ahead of the summer," said analyst Craig Erlam from Oanda.Afren plunges on recapitalisation planShares in Afren tumbled after the struggling oil and gas group proposed a debt-for-equity swap with creditors to address its funding needs and recapitalise its capital structure. The company said it "will result in substantial dilution for existing shareholders", and if shareholders don't approve the plan, the company will have no choice but to initiate a sale.Glasxosmithkline edged lower after selling half its stake in former South African associate Aspen Pharmacare for £0.57bn. Having sold 28.2m shares, at a price of 372 rand per share, GSK now holds a 6.2% stake in Aspen, South Africa's largest drug company.JD Wetherspoon served up a slightly short measure of first-half profits as the pubs group saw cost pressures outweigh a rise in revenues. Profits declined 0.9% in the first half while the interim dividend was maintained, causing shares to fall in London.Costa and Premier Inn owner Whitbread was racking up gains after UBS upgraded the stock to 'neutral' and Deustche Bank raised it to 'buy', while spirits group Diageo was lower after a downgrade by Credit Suisse to 'underperform'.Market MoverstechMARK 3,177.56 +0.33%FTSE 100 6,761.79 +0.01%FTSE 250 17,109.41 +0.28%FTSE 100 - RisersWhitbread (WTB) 5,400.00p +2.66%ARM Holdings (ARM) 1,180.00p +1.55%Meggitt (MGGT) 568.00p +1.52%Wolseley (WOS) 4,110.00p +1.46%British Land Co (BLND) 816.00p +1.37%Antofagasta (ANTO) 709.00p +1.21%GKN (GKN) 366.30p +1.19%Carnival (CCL) 3,132.00p +1.13%Fresnillo (FRES) 660.50p +1.07%Land Securities Group (LAND) 1,210.00p +1.00%FTSE 100 - FallersDiageo (DGE) 1,850.00p -1.70%SSE (SSE) 1,471.00p -1.34%Travis Perkins (TPK) 1,942.00p -1.27%Centrica (CNA) 238.60p -1.16%BG Group (BG.) 829.20p -1.12%Smiths Group (SMIN) 1,153.00p -1.11%BP (BP.) 421.95p -0.92%Sage Group (SGE) 472.40p -0.92%BHP Billiton (BLT) 1,424.00p -0.80%Ashtead Group (AHT) 1,107.00p -0.54%FTSE 250 - RisersThomas Cook Group (TCG) 155.10p +4.37%St. Modwen Properties (SMP) 454.50p +2.83%Bwin.party Digital Entertainment (BPTY) 81.75p +2.64%Allied Minds (ALM) 635.00p +2.50%Ladbrokes (LAD) 114.10p +2.33%Just Eat (JE.) 340.00p +2.22%Just Retirement Group (JRG) 155.20p +2.11%Workspace Group (WKP) 829.50p +2.09%Intermediate Capital Group (ICP) 483.80p +2.07%Grafton Group Units (GFTU) 780.00p +2.03%FTSE 250 - FallersAfren (AFR) 5.50p -15.38%Cairn Energy (CNE) 155.70p -3.41%Soco International (SIA) 153.40p -3.28%Wetherspoon (J.D.) (JDW) 785.00p -3.27%Hikma Pharmaceuticals (HIK) 2,288.00p -2.84%Lonmin (LMI) 107.90p -2.53%Vedanta Resources (VED) 514.50p -2.46%Cranswick (CWK) 1,378.00p -2.20%Premier Oil (PMO) 134.60p -1.97%Spire Healthcare Group (SPI) 323.70p -1.91%
More News
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.